Orthofix International N.V. (NASDAQ: OFIX) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its competitors? We will compare Orthofix International N.V. to related companies based on the strength of its valuation, profitability, analyst recommendations, institutional ownership, risk, earnings and dividends.
Risk and Volatility
Orthofix International N.V. has a beta of 0.2, indicating that its share price is 80% less volatile than the S&P 500. Comparatively, Orthofix International N.V.’s competitors have a beta of 1.06, indicating that their average share price is 6% more volatile than the S&P 500.
Earnings and Valuation
This table compares Orthofix International N.V. and its competitors revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Orthofix International N.V.||$418.71 million||$45.74 million||116.50|
|Orthofix International N.V. Competitors||$827.23 million||$159.49 million||36.37|
Orthofix International N.V.’s competitors have higher revenue and earnings than Orthofix International N.V.. Orthofix International N.V. is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This is a breakdown of recent recommendations for Orthofix International N.V. and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Orthofix International N.V.||0||0||5||0||3.00|
|Orthofix International N.V. Competitors||171||1123||2462||89||2.64|
Orthofix International N.V. currently has a consensus target price of $52.50, suggesting a potential upside of 7.30%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 9.34%. Given Orthofix International N.V.’s competitors higher probable upside, analysts plainly believe Orthofix International N.V. has less favorable growth aspects than its competitors.
Insider & Institutional Ownership
94.4% of Orthofix International N.V. shares are held by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 5.6% of Orthofix International N.V. shares are held by insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
This table compares Orthofix International N.V. and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Orthofix International N.V.||1.88%||9.96%||7.32%|
|Orthofix International N.V. Competitors||-127.07%||-36.30%||-10.21%|
Orthofix International N.V. beats its competitors on 7 of the 13 factors compared.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.